Dr. Ira Benzion Kurtz, MD

Dr. Kurtz practices at Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health.

Dr. Kurtz's NPI, 1538188990, was assigned on July 18, 2006. Dr. Kurtz graduated from University of Toronto Faculty of Medicine in 1977. Dr. Kurtz holds California license G43682.

Dr. Kurtz's primary practice is Ronald Reagan UCLA Medical Center, at 757 Westwood Plaza, Los Angeles, CA 90095 in Los Angeles County. The practice phone is (310) 825-6301.

Dr. Kurtz's primary practice is Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Kurtz to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kurtz practices, 2 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Kurtz's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Kurtz is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Kurtz's licenses on file in 2 states: California and Maryland.

Dmand AI lists acute kidney failure, chronic anemia and chronic kidney disease among the conditions Dr. Kurtz treats.

CMS data shows 18 Medicare services from Dr. Kurtz across 1 procedure code in 2024, all of them office visits, for 28 Medicare patients. Medicare paid $824 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 28 Medicare patients who saw Dr. Kurtz in 2024. The largest group is 75 to 84, with 12 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. Their average risk score is 2.26, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kurtz's median patient age at 63, with 60% women.

In 2024, Dr. Kurtz wrote 29 Medicare Part D claims. 97% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $60 in total drug cost. In 2019, CMS named 31 claims across 2 drugs.

Dr. Kurtz accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 136 papers to Dr. Kurtz, published from 2001 to 2025. 2018 was the busiest year, with 6. The most frequent topics are Sodium-Bicarbonate Symporters, Sodium and Bicarbonates. Dr. Kurtz has published most often in J Biol Chem. Dr. Kurtz's most frequent co-authors are Debra Newman, MD, Minhtri Khac Nguyen, MD and Ramy Magdy Hanna, MD.

CMS Open Payments shows 2 general payments to Dr. Kurtz from 2 drug and device companies from 2018 to 2019. Food and beverage make up the largest share, 100% of the total. Mallinckrodt Enterprises LLC paid the most, $73.

Dmand AI lists 2 awards for Dr. Kurtz, most recently Super Doc in 1991.

Dr. Kurtz graduated from University of Toronto Faculty of Medicine in 1977. Dr. Kurtz is a member of ASN.

Dr. Kurtz is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.